Benzinga | Nov 4, 2021 07:16AM EDT

HC Wainwright & Co. Downgrades BioDelivery Sciences Intl to Neutral, Lowers Price Target to $4.5

HC Wainwright & Co. analyst Oren Livnat downgrades BioDelivery Sciences Intl (NASDAQ:BDSI) from Buy to Neutral and lowers the price target from $6 to $4.5.